SPRB · Spruce Biosciences, Inc.
$42.28
-2.71 (-6.02%)
At close · Jul 24
Market Cap
$118.57M
Shares
2.75M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Javier Szwarcberg | CEO | $2,910,573 |
| Samir Gharib | CFO | $1,473,211 |
| Kirk Ways | Interim Chief Medical Officer | $1,044,412 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Javier Szwarcberg | CEO | $1,532,187 |
| Ralph William Charlton III | Chief Medical Officer | $1,161,336 |
| Samir Gharib | CFO | $929,690 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Javier Szwarcberg | CEO | $2,157,418 |
| Samir Gharib | CFO | $1,201,066 |
| Ralph William Charlton III | Chief Medical Officer | $1,004,904 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Javier Szwarcberg | CEO | $4,490,855 |
| Samir Gharib | CFO | $975,361 |
| Ralph William Charlton III | Chief Medical Officer | $962,358 |
| Michael Grey | CEO | $99,700 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Richard King | CEO | $5,106,007 |
| Samir Gharib | CFO | $2,194,295 |
| Rosh Dias | Chief Medical Officer | $1,105,614 |
| Michael Grey | CEO | $732,303 |
| Javier Szwarcberg | CEO | — |
| Ralph William Charlton III | Chief Medical Officer | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Richard King | CEO | $2,467,526 |
| Rosh Dias | Chief Medical Officer | $1,680,448 |
| Samir Gharib | CFO | $793,384 |
| Michael Grey | CEO | $622,888 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Richard King | CEO | $549,766 |
| Rosh Dias | Chief Medical Officer | — |
| Samir Gharib | CFO | — |